Médecine

Paramédical

Autres domaines


S'abonner

Tumeur à cellules géantes pendant la grossesse : Une revue de la littérature - 22/09/22

The giant cell tumor during pregnancy: A review of literature

Doi : 10.1016/j.rcot.2022.09.007 
Virginia M. Formica a, f, Valentina Bruno b, f, Alessandra Scotto Di Uccio c, f, Emilio Cocca d, f, Barbara Rossi e, f, Carmine Zoccali d, e, f,
a Hand and Microsurgery Unit, Jewish Hospital, via Fulda, 14, 00148 Rome, Italie 
b Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, via Elio Chianesi, 53, 00144 Rome, Italie 
c School of General Surgery, General Surgery and Organ Transplantation Unit, Umberto I Polyclinic of Rome, Sapienza University, viale del Policlinico, 155, 00161 Rome, Italie 
d Orthopaedic and Traumatology Unit, Department of General Surgery, Plastic Surgery, Orthopedics, Policlinico Umberto I Hospital-Sapienza, University of Rome, Piazzale Aldo-Moro, 3, 00185 Rome, Italie 
e Oncological Orthopaedics Department. IRCCS - Regina Elena National Cancer Institute, via Elio Chianesi, 53, 00144 Rome, Italie 
f IRCCS - Regina Elena National Cancer Institute, via Elio Chianesi, 53, 00144 Rome, Italie 

Auteur correspondant.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Thursday 22 September 2022

Abstract

Background

Giant cell tumors (GTC) of bone are benign, locally aggressive tumors generally occurring in young people with a female predominance during reproductive age. Considering their worsening during pregnancy it has been suggested that pregnancy can accelerate GCT progression or favor recurrence but correlation between tumor growth and pregnancy has not yet been clarified. Aim of this study was to clarify clinical characteristics, timing and type of treatment through a literature review on GTCs occurring during pregnancy.

Patients and Methods

An electronic search was performed in December 2020 in PubMed, Scopus, Embase, Medline, Cochrane Register using the keywords “giant cell tumor” and “pregnancy” looking for papers reporting cases of giant cell tumors of the bone onset or recurred during pregnancy. The electronic search identified 212 papers; sixteen studies were selected, for a total of 32 cases.

Results

The diagnosis was made during pregnancy in 24 cases and after the partum in 8 cases. 27 cases were new diagnoses while 5 cases were recurrences. Pulmonary metastases were reported in 3 patients. The treatment was performed during the pregnancy in 7 out of 32 cases; in the remaining 27 cases treatment was performed after delivery. The hormone receptor status was reported in 14 patients. Data regarding follow-up was reported for 26 out of 32 patients; three patients had local recurrences that were treated with wide resection and amputation in 2 and 1 case, respectively; at the last follow-up all patients were apparently without any evidence of disease except for three patients who had stable lung metastases.

Discussion

In case of GCT during pregnancy, a multidisciplinary approach is necessary to offer the patients the best treatment in terms of mother and child's health. A correct diagnosis is necessary and not confusing tumor symptoms with ones of pregnancy is mandatory in order not to delay the diagnosis and let the tumor progress. Actually, even though pregnancy would seem to promote GCT growth and aggressiveness, the relationship is not clear. More studies are necessary to clarify this interesting aspect.

Level of Evidence

IV, systematic review.

Le texte complet de cet article est disponible en PDF.

Keywords : GCT, Pregnancy, Estrogen receptors, Progesterone receptors, Delivery



© 2022  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.